EGFR and colorectal cancer: Two signaling pathways downstream of the epidermal growth factor receptor (EGFR) are dysregulated in the majority of colorectal cancers (CRC): the mitogen-activated protein kinase (MAPK) and the phosphoinositide-3-kinase (PI3K) pathway.